Global Parkinson's Disease Treatment Market Research Report 2018
- QYR2811950
- 128 Pages
- November 2018
- Pharmaceuticals
This report studies the global Parkinson's Disease Treatment market status and forecast, categorizes the global Parkinson's Disease Treatment market size (value & volume) by manufacturers, type, application, and region. This report focuses on the top manufacturers in North America, Europe, Japan, China, and other regions (India, Southeast Asia).
The major manufacturers covered in this report
Teva (Israel)
Novartis AG (Switzerland)
GSK (UK)
AbbVie (US)
Merck (US)
Boehringer Ingelheim (Germany)
Impax Laboratories (US)
Lundbeck (Denmark)
UCB (Belgium)
Valeant Pharmaceuticals (Canada)
Acadia (US)
Sun Pharma (India)
Wockhardt (India)
Dr. Reddy's (India)
Intas (India)
US WorldMeds (US)
Zydus Cadila (India)
Cipla (India)
Geographically, this report studies the top producers and consumers, focuses on product capacity, production, value, consumption, market share and growth opportunity in these key regions, covering
North America
Europe
China
Japan
Southeast Asia
India
We can also provide the customized separate regional or country-level reports, for the following regions:
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Rest of Asia-Pacific
Europe
Germany
France
UK
Italy
Spain
Russia
Rest of Europe
Central & South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Saudi Arabia
Turkey
Rest of Middle East & Africa
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
Levodopa/carbidopa
Dopamine Receptor Agonists
MAO-Inhibitors
COMT-inhibitors
Anticholinergics
Other Drugs
On the basis of the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate for each application, including
Hospital Pharmacies
Retailer Pharmacies
Online Pharmacies
The study objectives of this report are:
To analyze and study the global Parkinson's Disease Treatment capacity, production, value, consumption, status (2013-2017) and forecast (2018-2025);
Focuses on the key Parkinson's Disease Treatment manufacturers, to study the capacity, production, value, market share and development plans in future.
Focuses on the global key manufacturers, to define, describe and analyze the market competition landscape, SWOT analysis.
To define, describe and forecast the market by type, application and region.
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends and factors driving or inhibiting the market growth.
To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
To strategically analyze each submarket with respect to individual growth trend and their contribution to the market
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
To strategically profile the key players and comprehensively analyze their growth strategies.
In this study, the years considered to estimate the market size of Parkinson's Disease Treatment are as follows:
History Year: 2013-2017
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025
For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Key Stakeholders
Parkinson's Disease Treatment Manufacturers
Parkinson's Disease Treatment Distributors/Traders/Wholesalers
Parkinson's Disease Treatment Subcomponent Manufacturers
Industry Association
Downstream Vendors
Available Customizations
With the given market data, QYResearch offers customizations according to the company's specific needs. The following customization options are available for the report:
Regional and country-level analysis of the Parkinson's Disease Treatment market, by end-use.
Detailed analysis and profiles of additional market players.
Global Parkinson's Disease Treatment Market Research Report 2018
1 Parkinson's Disease Treatment Market Overview
1.1 Product Overview and Scope of Parkinson's Disease Treatment
1.2 Parkinson's Disease Treatment Segment by Type (Product Category)
1.2.1 Global Parkinson's Disease Treatment Production and CAGR (%) Comparison by Type (Product Category)(2013-2025)
1.2.2 Global Parkinson's Disease Treatment Production Market Share by Type (Product Category) in 2017
1.2.3 Levodopa/carbidopa
1.2.3 Dopamine Receptor Agonists
1.2.5 MAO-Inhibitors
1.2.6 COMT-inhibitors
1.2.7 Anticholinergics
Other Drugs
1.3 Global Parkinson's Disease Treatment Segment by Application
1.3.1 Parkinson's Disease Treatment Consumption (Sales) Comparison by Application (2013-2025)
1.3.2 Hospital Pharmacies
1.3.3 Retailer Pharmacies
1.3.4 Online Pharmacies
1.4 Global Parkinson's Disease Treatment Market by Region (2013-2025)
1.4.1 Global Parkinson's Disease Treatment Market Size (Value) and CAGR (%) Comparison by Region (2013-2025)
1.4.2 North America Status and Prospect (2013-2025)
1.4.3 Europe Status and Prospect (2013-2025)
1.4.4 China Status and Prospect (2013-2025)
1.4.5 Japan Status and Prospect (2013-2025)
1.4.6 Southeast Asia Status and Prospect (2013-2025)
1.4.7 India Status and Prospect (2013-2025)
1.5 Global Market Size (Value) of Parkinson's Disease Treatment (2013-2025)
1.5.1 Global Parkinson's Disease Treatment Revenue Status and Outlook (2013-2025)
1.5.2 Global Parkinson's Disease Treatment Capacity, Production Status and Outlook (2013-2025)
2 Global Parkinson's Disease Treatment Market Competition by Manufacturers
2.1 Global Parkinson's Disease Treatment Capacity, Production and Share by Manufacturers (2013-2018)
2.1.1 Global Parkinson's Disease Treatment Capacity and Share by Manufacturers (2013-2018)
2.1.2 Global Parkinson's Disease Treatment Production and Share by Manufacturers (2013-2018)
2.2 Global Parkinson's Disease Treatment Revenue and Share by Manufacturers (2013-2018)
2.3 Global Parkinson's Disease Treatment Average Price by Manufacturers (2013-2018)
2.4 Manufacturers Parkinson's Disease Treatment Manufacturing Base Distribution, Sales Area and Product Type
2.5 Parkinson's Disease Treatment Market Competitive Situation and Trends
2.5.1 Parkinson's Disease Treatment Market Concentration Rate
2.5.2 Parkinson's Disease Treatment Market Share of Top 3 and Top 5 Manufacturers
2.5.3 Mergers & Acquisitions, Expansion
3 Global Parkinson's Disease Treatment Capacity, Production, Revenue (Value) by Region (2013-2018)
3.1 Global Parkinson's Disease Treatment Capacity and Market Share by Region (2013-2018)
3.2 Global Parkinson's Disease Treatment Production and Market Share by Region (2013-2018)
3.3 Global Parkinson's Disease Treatment Revenue (Value) and Market Share by Region (2013-2018)
3.4 Global Parkinson's Disease Treatment Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.5 North America Parkinson's Disease Treatment Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.6 Europe Parkinson's Disease Treatment Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.7 China Parkinson's Disease Treatment Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.8 Japan Parkinson's Disease Treatment Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.9 Southeast Asia Parkinson's Disease Treatment Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.10 India Parkinson's Disease Treatment Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
4 Global Parkinson's Disease Treatment Supply (Production), Consumption, Export, Import by Region (2013-2018)
4.1 Global Parkinson's Disease Treatment Consumption by Region (2013-2018)
4.2 North America Parkinson's Disease Treatment Production, Consumption, Export, Import (2013-2018)
4.3 Europe Parkinson's Disease Treatment Production, Consumption, Export, Import (2013-2018)
4.4 China Parkinson's Disease Treatment Production, Consumption, Export, Import (2013-2018)
4.5 Japan Parkinson's Disease Treatment Production, Consumption, Export, Import (2013-2018)
4.6 Southeast Asia Parkinson's Disease Treatment Production, Consumption, Export, Import (2013-2018)
4.7 India Parkinson's Disease Treatment Production, Consumption, Export, Import (2013-2018)
5 Global Parkinson's Disease Treatment Production, Revenue (Value), Price Trend by Type
5.1 Global Parkinson's Disease Treatment Production and Market Share by Type (2013-2018)
5.2 Global Parkinson's Disease Treatment Revenue and Market Share by Type (2013-2018)
5.3 Global Parkinson's Disease Treatment Price by Type (2013-2018)
5.4 Global Parkinson's Disease Treatment Production Growth by Type (2013-2018)
6 Global Parkinson's Disease Treatment Market Analysis by Application
6.1 Global Parkinson's Disease Treatment Consumption and Market Share by Application (2013-2018)
6.2 Global Parkinson's Disease Treatment Consumption Growth Rate by Application (2013-2018)
6.3 Market Drivers and Opportunities
6.3.1 Potential Applications
6.3.2 Emerging Markets/Countries
7 Global Parkinson's Disease Treatment Manufacturers Profiles/Analysis
7.1 Teva (Israel)
7.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.1.2 Parkinson's Disease Treatment Product Category, Application and Specification
7.1.2.1 Product A
7.1.2.2 Product B
7.1.3 Teva (Israel) Parkinson's Disease Treatment Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.1.4 Main Business/Business Overview
7.2 Novartis AG (Switzerland)
7.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.2.2 Parkinson's Disease Treatment Product Category, Application and Specification
7.2.2.1 Product A
7.2.2.2 Product B
7.2.3 Novartis AG (Switzerland) Parkinson's Disease Treatment Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.2.4 Main Business/Business Overview
7.3 GSK (UK)
7.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.3.2 Parkinson's Disease Treatment Product Category, Application and Specification
7.3.2.1 Product A
7.3.2.2 Product B
7.3.3 GSK (UK) Parkinson's Disease Treatment Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.3.4 Main Business/Business Overview
7.4 AbbVie (US)
7.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.4.2 Parkinson's Disease Treatment Product Category, Application and Specification
7.4.2.1 Product A
7.4.2.2 Product B
7.4.3 AbbVie (US) Parkinson's Disease Treatment Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.4.4 Main Business/Business Overview
7.5 Merck (US)
7.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.5.2 Parkinson's Disease Treatment Product Category, Application and Specification
7.5.2.1 Product A
7.5.2.2 Product B
7.5.3 Merck (US) Parkinson's Disease Treatment Capacity, Production, Revenue, Price and Gross Margin (2015-2018)
7.5.4 Main Business/Business Overview
7.6 Boehringer Ingelheim (Germany)
7.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.6.2 Parkinson's Disease Treatment Product Category, Application and Specification
7.6.2.1 Product A
7.6.2.2 Product B
7.6.3 Boehringer Ingelheim (Germany) Parkinson's Disease Treatment Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.6.4 Main Business/Business Overview
7.7 Impax Laboratories (US)
7.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.7.2 Parkinson's Disease Treatment Product Category, Application and Specification
7.7.2.1 Product A
7.7.2.2 Product B
7.7.3 Impax Laboratories (US) Parkinson's Disease Treatment Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.7.4 Main Business/Business Overview
7.8 Lundbeck (Denmark)
7.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.8.2 Parkinson's Disease Treatment Product Category, Application and Specification
7.8.2.1 Product A
7.8.2.2 Product B
7.8.3 Lundbeck (Denmark) Parkinson's Disease Treatment Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.8.4 Main Business/Business Overview
7.9 UCB (Belgium)
7.9.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.9.2 Parkinson's Disease Treatment Product Category, Application and Specification
7.9.2.1 Product A
7.9.2.2 Product B
7.9.3 UCB (Belgium) Parkinson's Disease Treatment Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.9.4 Main Business/Business Overview
7.8 Valeant Pharmaceuticals (Canada)
7.10.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.10.2 Parkinson's Disease Treatment Product Category, Application and Specification
7.10.2.1 Product A
7.10.2.2 Product B
7.10.3 Valeant Pharmaceuticals (Canada) Parkinson's Disease Treatment Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.10.4 Main Business/Business Overview
7.11 Acadia (US)
7.12 Sun Pharma (India)
7.13 Wockhardt (India)
7.14 Dr. Reddy's (India)
7.15 Intas (India)
7.16 US WorldMeds (US)
7.17 Zydus Cadila (India)
7.18 Cipla (India)
8 Parkinson's Disease Treatment Manufacturing Cost Analysis
8.1 Parkinson's Disease Treatment Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Price Trend of Key Raw Materials
8.1.3 Key Suppliers of Raw Materials
8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.2.1 Raw Materials
8.2.2 Labor Cost
8.2.3 Manufacturing Expenses
8.3 Manufacturing Process Analysis of Parkinson's Disease Treatment
9 Industrial Chain, Sourcing Strategy and Downstream Buyers
9.1 Parkinson's Disease Treatment Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of Parkinson's Disease Treatment Major Manufacturers in 2017
9.4 Downstream Buyers
10 Marketing Strategy Analysis, Distributors/Traders
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List
11 Market Effect Factors Analysis
11.1 Technology Progress/Risk
11.1.1 Substitutes Threat
11.1.2 Technology Progress in Related Industry
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change
12 Global Parkinson's Disease Treatment Market Forecast (2018-2025)
12.1 Global Parkinson's Disease Treatment Capacity, Production, Revenue Forecast (2018-2025)
12.1.1 Global Parkinson's Disease Treatment Capacity, Production and Growth Rate Forecast (2018-2025)
12.1.2 Global Parkinson's Disease Treatment Revenue and Growth Rate Forecast (2018-2025)
12.1.3 Global Parkinson's Disease Treatment Price and Trend Forecast (2018-2025)
12.2 Global Parkinson's Disease Treatment Production, Consumption , Import and Export Forecast by Region (2018-2025)
12.2.1 North America Parkinson's Disease Treatment Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
12.2.2 Europe Parkinson's Disease Treatment Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
12.2.3 China Parkinson's Disease Treatment Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
12.2.4 Japan Parkinson's Disease Treatment Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
12.2.5 Southeast Asia Parkinson's Disease Treatment Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
12.2.6 India Parkinson's Disease Treatment Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
12.3 Global Parkinson's Disease Treatment Production, Revenue and Price Forecast by Type (2018-2025)
12.4 Global Parkinson's Disease Treatment Consumption Forecast by Application (2018-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology/Research Approach
14.1.1 Research Programs/Design
14.1.2 Market Size Estimation
14.1.3 Market Breakdown and Data Triangulation
14.2 Data Source
14.2.1 Secondary Sources
14.2.2 Primary Sources
14.3 Disclaimer
Figure Picture of Parkinson's Disease Treatment
Figure Global Parkinson's Disease Treatment Production (K Units) and CAGR (%) Comparison by Types (Product Category) (2013-2025)
Figure Global Parkinson's Disease Treatment Production Market Share by Types (Product Category) in 2017
Figure Product Picture of Levodopa/carbidopa
Table Major Manufacturers of Levodopa/carbidopa
Figure Product Picture of Dopamine Receptor Agonists
Table Major Manufacturers of Dopamine Receptor Agonists
Figure Product Picture of MAO-Inhibitors
Table Major Manufacturers of MAO-Inhibitors
Figure Product Picture of COMT-inhibitors
Table Major Manufacturers of COMT-inhibitors
Figure Product Picture of Anticholinergics
Table Major Manufacturers of Anticholinergics
Figure Product Picture of Other Drugs
Table Major Manufacturers of Other Drugs
Figure Global Parkinson's Disease Treatment Consumption (K Units) by Applications (2013-2025)
Figure Hospital Pharmacies Examples
Table Key Downstream Customer in Hospital Pharmacies
Figure Retailer Pharmacies Examples
Table Key Downstream Customer in Retailer Pharmacies
Figure Online Pharmacies Examples
Table Key Downstream Customer in Online Pharmacies
Figure Global Parkinson's Disease Treatment Market Size (Million USD), Comparison (K Units) and CAGR (%) by Regions (2013-2025)
Figure North America Parkinson's Disease Treatment Revenue (Million USD) and Growth Rate (2013-2025)
Figure Europe Parkinson's Disease Treatment Revenue (Million USD) and Growth Rate (2013-2025)
Figure China Parkinson's Disease Treatment Revenue (Million USD) and Growth Rate (2013-2025)
Figure Japan Parkinson's Disease Treatment Revenue (Million USD) and Growth Rate (2013-2025)
Figure Southeast Asia Parkinson's Disease Treatment Revenue (Million USD) and Growth Rate (2013-2025)
Figure India Parkinson's Disease Treatment Revenue (Million USD) and Growth Rate (2013-2025)
Figure Global Parkinson's Disease Treatment Revenue (Million USD) Status and Outlook (2013-2025)
Figure Global Parkinson's Disease Treatment Capacity, Production (K Units) Status and Outlook (2013-2025)
Figure Global Parkinson's Disease Treatment Major Players Product Capacity (K Units) (2013-2018)
Table Global Parkinson's Disease Treatment Capacity (K Units) of Key Manufacturers (2013-2018)
Table Global Parkinson's Disease Treatment Capacity Market Share of Key Manufacturers (2013-2018)
Figure Global Parkinson's Disease Treatment Capacity (K Units) of Key Manufacturers in 2017
Figure Global Parkinson's Disease Treatment Capacity (K Units) of Key Manufacturers in 2018
Figure Global Parkinson's Disease Treatment Major Players Product Production (K Units) (2013-2018)
Table Global Parkinson's Disease Treatment Production (K Units) of Key Manufacturers (2013-2018)
Table Global Parkinson's Disease Treatment Production Share by Manufacturers (2013-2018)
Figure 2017 Parkinson's Disease Treatment Production Share by Manufacturers
Figure 2017 Parkinson's Disease Treatment Production Share by Manufacturers
Figure Global Parkinson's Disease Treatment Major Players Product Revenue (Million USD) (2013-2018)
Table Global Parkinson's Disease Treatment Revenue (Million USD) by Manufacturers (2013-2018)
Table Global Parkinson's Disease Treatment Revenue Share by Manufacturers (2013-2018)
Table 2017 Global Parkinson's Disease Treatment Revenue Share by Manufacturers
Table 2018 Global Parkinson's Disease Treatment Revenue Share by Manufacturers
Table Global Market Parkinson's Disease Treatment Average Price (USD/Unit) of Key Manufacturers (2013-2018)
Figure Global Market Parkinson's Disease Treatment Average Price (USD/Unit) of Key Manufacturers in 2017
Table Manufacturers Parkinson's Disease Treatment Manufacturing Base Distribution and Sales Area
Table Manufacturers Parkinson's Disease Treatment Product Category
Figure Parkinson's Disease Treatment Market Share of Top 3 Manufacturers
Figure Parkinson's Disease Treatment Market Share of Top 5 Manufacturers
Table Global Parkinson's Disease Treatment Capacity (K Units) by Region (2013-2018)
Figure Global Parkinson's Disease Treatment Capacity Market Share by Region (2013-2018)
Figure Global Parkinson's Disease Treatment Capacity Market Share by Region (2013-2018)
Figure 2017 Global Parkinson's Disease Treatment Capacity Market Share by Region
Table Global Parkinson's Disease Treatment Production by Region (2013-2018)
Figure Global Parkinson's Disease Treatment Production (K Units) by Region (2013-2018)
Figure Global Parkinson's Disease Treatment Production Market Share by Region (2013-2018)
Figure 2017 Global Parkinson's Disease Treatment Production Market Share by Region
Table Global Parkinson's Disease Treatment Revenue (Million USD) by Region (2013-2018)
Table Global Parkinson's Disease Treatment Revenue Market Share by Region (2013-2018)
Figure Global Parkinson's Disease Treatment Revenue Market Share by Region (2013-2018)
Table 2017 Global Parkinson's Disease Treatment Revenue Market Share by Region
Figure Global Parkinson's Disease Treatment Capacity, Production (K Units) and Growth Rate (2013-2018)
Table Global Parkinson's Disease Treatment Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Table North America Parkinson's Disease Treatment Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Table Europe Parkinson's Disease Treatment Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Table China Parkinson's Disease Treatment Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Table Japan Parkinson's Disease Treatment Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Table Southeast Asia Parkinson's Disease Treatment Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Table India Parkinson's Disease Treatment Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Table Global Parkinson's Disease Treatment Consumption (K Units) Market by Region (2013-2018)
Table Global Parkinson's Disease Treatment Consumption Market Share by Region (2013-2018)
Figure Global Parkinson's Disease Treatment Consumption Market Share by Region (2013-2018)
Figure 2017 Global Parkinson's Disease Treatment Consumption (K Units) Market Share by Region
Table North America Parkinson's Disease Treatment Production, Consumption, Import & Export (K Units) (2013-2018)
Table Europe Parkinson's Disease Treatment Production, Consumption, Import & Export (K Units) (2013-2018)
Table China Parkinson's Disease Treatment Production, Consumption, Import & Export (K Units) (2013-2018)
Table Japan Parkinson's Disease Treatment Production, Consumption, Import & Export (K Units) (2013-2018)
Table Southeast Asia Parkinson's Disease Treatment Production, Consumption, Import & Export (K Units) (2013-2018)
Table India Parkinson's Disease Treatment Production, Consumption, Import & Export (K Units) (2013-2018)
Table Global Parkinson's Disease Treatment Production (K Units) by Type (2013-2018)
Table Global Parkinson's Disease Treatment Production Share by Type (2013-2018)
Figure Production Market Share of Parkinson's Disease Treatment by Type (2013-2018)
Figure 2017 Production Market Share of Parkinson's Disease Treatment by Type
Table Global Parkinson's Disease Treatment Revenue (Million USD) by Type (2013-2018)
Table Global Parkinson's Disease Treatment Revenue Share by Type (2013-2018)
Figure Production Revenue Share of Parkinson's Disease Treatment by Type (2013-2018)
Figure 2017 Revenue Market Share of Parkinson's Disease Treatment by Type
Table Global Parkinson's Disease Treatment Price (USD/Unit) by Type (2013-2018)
Figure Global Parkinson's Disease Treatment Production Growth by Type (2013-2018)
Table Global Parkinson's Disease Treatment Consumption (K Units) by Application (2013-2018)
Table Global Parkinson's Disease Treatment Consumption Market Share by Application (2013-2018)
Figure Global Parkinson's Disease Treatment Consumption Market Share by Applications (2013-2018)
Figure Global Parkinson's Disease Treatment Consumption Market Share by Application in 2017
Table Global Parkinson's Disease Treatment Consumption Growth Rate by Application (2013-2018)
Figure Global Parkinson's Disease Treatment Consumption Growth Rate by Application (2013-2018)
Table Teva (Israel) Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Teva (Israel) Parkinson's Disease Treatment Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Teva (Israel) Parkinson's Disease Treatment Production Growth Rate (2013-2018)
Figure Teva (Israel) Parkinson's Disease Treatment Production Market Share (2013-2018)
Figure Teva (Israel) Parkinson's Disease Treatment Revenue Market Share (2013-2018)
Table Novartis AG (Switzerland) Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Novartis AG (Switzerland) Parkinson's Disease Treatment Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Novartis AG (Switzerland) Parkinson's Disease Treatment Production Growth Rate (2013-2018)
Figure Novartis AG (Switzerland) Parkinson's Disease Treatment Production Market Share (2013-2018)
Figure Novartis AG (Switzerland) Parkinson's Disease Treatment Revenue Market Share (2013-2018)
Table GSK (UK) Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table GSK (UK) Parkinson's Disease Treatment Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure GSK (UK) Parkinson's Disease Treatment Production Growth Rate (2013-2018)
Figure GSK (UK) Parkinson's Disease Treatment Production Market Share (2013-2018)
Figure GSK (UK) Parkinson's Disease Treatment Revenue Market Share (2013-2018)
Table AbbVie (US) Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table AbbVie (US) Parkinson's Disease Treatment Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure AbbVie (US) Parkinson's Disease Treatment Production Growth Rate (2013-2018)
Figure AbbVie (US) Parkinson's Disease Treatment Production Market Share (2013-2018)
Figure AbbVie (US) Parkinson's Disease Treatment Revenue Market Share (2013-2018)
Table Merck (US) Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Merck (US) Parkinson's Disease Treatment Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Merck (US) Parkinson's Disease Treatment Production Growth Rate (2013-2018)
Figure Merck (US) Parkinson's Disease Treatment Production Market Share (2013-2018)
Figure Merck (US) Parkinson's Disease Treatment Revenue Market Share (2013-2018)
Table Boehringer Ingelheim (Germany) Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Boehringer Ingelheim (Germany) Parkinson's Disease Treatment Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Boehringer Ingelheim (Germany) Parkinson's Disease Treatment Production Growth Rate (2013-2018)
Figure Boehringer Ingelheim (Germany) Parkinson's Disease Treatment Production Market Share (2013-2018)
Figure Boehringer Ingelheim (Germany) Parkinson's Disease Treatment Revenue Market Share (2013-2018)
Table Impax Laboratories (US) Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Impax Laboratories (US) Parkinson's Disease Treatment Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Impax Laboratories (US) Parkinson's Disease Treatment Production Growth Rate (2013-2018)
Figure Impax Laboratories (US) Parkinson's Disease Treatment Production Market Share (2013-2018)
Figure Impax Laboratories (US) Parkinson's Disease Treatment Revenue Market Share (2013-2018)
Table Lundbeck (Denmark) Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Lundbeck (Denmark) Parkinson's Disease Treatment Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Lundbeck (Denmark) Parkinson's Disease Treatment Production Growth Rate (2013-2018)
Figure Lundbeck (Denmark) Parkinson's Disease Treatment Production Market Share (2013-2018)
Figure Lundbeck (Denmark) Parkinson's Disease Treatment Revenue Market Share (2013-2018)
Table UCB (Belgium) Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table UCB (Belgium) Parkinson's Disease Treatment Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure UCB (Belgium) Parkinson's Disease Treatment Production Growth Rate (2013-2018)
Figure UCB (Belgium) Parkinson's Disease Treatment Production Market Share (2013-2018)
Figure UCB (Belgium) Parkinson's Disease Treatment Revenue Market Share (2013-2018)
Table Valeant Pharmaceuticals (Canada) Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Valeant Pharmaceuticals (Canada) Parkinson's Disease Treatment Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Valeant Pharmaceuticals (Canada) Parkinson's Disease Treatment Production Growth Rate (2013-2018)
Figure Valeant Pharmaceuticals (Canada) Parkinson's Disease Treatment Production Market Share (2013-2018)
Figure Valeant Pharmaceuticals (Canada) Parkinson's Disease Treatment Revenue Market Share (2013-2018)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Parkinson's Disease Treatment
Figure Manufacturing Process Analysis of Parkinson's Disease Treatment
Figure Parkinson's Disease Treatment Industrial Chain Analysis
Table Raw Materials Sources of Parkinson's Disease Treatment Major Manufacturers in 2017
Table Major Buyers of Parkinson's Disease Treatment
Table Distributors/Traders List
Figure Global Parkinson's Disease Treatment Capacity, Production (K Units) and Growth Rate Forecast (2018-2025)
Figure Global Parkinson's Disease Treatment Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Global Parkinson's Disease Treatment Price (Million USD) and Trend Forecast (2018-2025)
Table Global Parkinson's Disease Treatment Production (K Units) Forecast by Region (2018-2025)
Figure Global Parkinson's Disease Treatment Production Market Share Forecast by Region (2018-2025)
Table Global Parkinson's Disease Treatment Consumption (K Units) Forecast by Region (2018-2025)
Figure Global Parkinson's Disease Treatment Consumption Market Share Forecast by Region (2018-2025)
Figure North America Parkinson's Disease Treatment Production (K Units) and Growth Rate Forecast (2018-2025)
Figure North America Parkinson's Disease Treatment Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Table North America Parkinson's Disease Treatment Production, Consumption, Export and Import (K Units) Forecast (2018-2025)
Figure Asia-Pacific Parkinson's Disease Treatment Production (K Units) and Growth Rate Forecast (2018-2025)
Figure Asia-Pacific Parkinson's Disease Treatment Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Table Asia-Pacific Parkinson's Disease Treatment Production, Consumption, Export and Import (K Units) Forecast (2018-2025)
Figure Europe Parkinson's Disease Treatment Production (K Units) and Growth Rate Forecast (2018-2025)
Figure Europe Parkinson's Disease Treatment Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Table Europe Parkinson's Disease Treatment Production, Consumption, Export and Import (K Units) Forecast (2018-2025)
Figure Central & South America Parkinson's Disease Treatment Production (K Units) and Growth Rate Forecast (2018-2025)
Figure Central & South America Parkinson's Disease Treatment Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Table Central & South America Parkinson's Disease Treatment Production, Consumption, Export and Import (K Units) Forecast (2018-2025)
Figure Southeast Asia Parkinson's Disease Treatment Production (K Units) and Growth Rate Forecast (2018-2025)
Figure Southeast Asia Parkinson's Disease Treatment Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Table Southeast Asia Parkinson's Disease Treatment Production, Consumption, Export and Import (K Units) Forecast (2018-2025)
Figure India Parkinson's Disease Treatment Production (K Units) and Growth Rate Forecast (2018-2025)
Figure India Parkinson's Disease Treatment Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Table India Parkinson's Disease Treatment Production, Consumption, Export and Import (K Units) Forecast (2018-2025)
Table Global Parkinson's Disease Treatment Production (K Units) Forecast by Type (2018-2025)
Figure Global Parkinson's Disease Treatment Production (K Units) Forecast by Type (2018-2025)
Table Global Parkinson's Disease Treatment Revenue (Million USD) Forecast by Type (2018-2025)
Figure Global Parkinson's Disease Treatment Revenue Market Share Forecast by Type (2018-2025)
Table Global Parkinson's Disease Treatment Price Forecast by Type (2018-2025)
Table Global Parkinson's Disease Treatment Consumption (K Units) Forecast by Application (2018-2025)
Figure Global Parkinson's Disease Treatment Consumption (K Units) Forecast by Application (2018-2025)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Source
Similar Reports
Proteins that are designed and engineered in the laboratory for pharmaceutical interventions to treat different diseases are known as protein therapeutics. The global protein therapeutics market accounted for $140,109 million in 2016, and is anticipated to rea...
- Publish Date: November 14, 2017
- $5370
Umbilical cord blood bank is storage facility that collects cord blood after the childbirth from placenta. Cord blood is rich source of stem cell used in treatment of different chronic diseases. Private and public cord blood banks are the two major types of banks that are prevalent in th...
- Publish Date: July 20, 2017
- $5370
The pharmaceutical agents that are administered to treat, diagnose, and prevent life-threatening diseases (rare diseases) are known as orphan drugs. The global orphan drugs market accounted for $106 billion in 2015, and is anticipated to reach $169 billio...
- Publish Date: April 24, 2017
- $5370
